80 results about "Diminution" patented technology

The present invention is directed to a combination of therapeutic compounds and treatment methods and kits using the combination. In particular, one of the combination affects the NCca-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system. Exemplary SUR1 and/or TRPM4 antagonists that inhibit the NCca-ATP channel may be employed in the combination. The combination therapy also employs one or more of a non-selective cation channel blocker and/or an antagonist of VEFG, NOS, MMP, or thrombin. Exemplary indications for the combination therapy includes the prevention, diminution, and/or treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury, for example. In other embodiments, there are methods and compositions directed to antagonists of TRPM4, including at least for therapeutic treatment of traumatic brain injury, cerebral ischemia, central nervous system (CNS) damage, peripheral nervous system (PNS) damage, cerebral hypoxia, or edema, for example.

The current invention relates to an adjustable mandibular advancement device with a unique combination of resilient hinging and adjustability to prevent or reduce snoring and/or obstructive sleep apnea syndrome. The adjustability is described by means of two concepts of adjustability for the relative enlargement or diminution of the members of the device, incremental and successive advancement mechanisms, in either combination or separately. By use of thermoplastic materials the device can be used in the outmost variability of the human dentition.

The invention discloses a beef ball which comprises main materials and auxiliary materials, wherein the main materials comprise the following components in parts by weight: 20-30 parts of beef, 2-4 parts of starch, 4-6 parts of soy isolate protein, 10-12 parts of icy water, 3-5 parts of chicken breast meat and 1-2 parts of egg liquid; the auxiliary materials are added according to the percentage of the weight of the main materials; the auxiliary materials comprise the following components in percentage by weight of the main materials: 0.5-2% of salt, 1-2.5% of sugar, 0.2-0.6% of aginomoto, 1-1.5% of fried shallot, 0.05-0.1% of beef flavor, 2-3% of soybean sauce and 1-2% of lycium barbarum. The beef ball is rich in nutrition and rich in protein, vitamin and microelement; the nutrient components of the livestock and poultry meat complement with one another; the skin is soft, crispy, very chewable, thick in fragrance and fragrant, tender and tasty; due to the adoption of lycium barbarum, the beef ball has the functions of nourishing the kidney and strengthening the essence, nourishing the liver to brighten the eye and moistening lung to arrest cough, and has a good tonifying function for people with blood and qi deficiency, weak constitution, vision diminution, anemia, chronic hepatitis, toxic or metabolism liver diseases and biliary system diseases.

Disclosed is a Chinese proprietary medicine wherein the raw materials mainly include tuber of multiflower knotweed and other Chinese medicinal herbs. The medicament can be used for treating nervous prostration, pseudomyopia, diminution of vision, vision fatigue, abnormal menstruation, hypertension, hyperlipemia and alopecia.

The invention relates to an eye drop used for releasing eye fatigue and a preparation method thereof. The eye drop comprises following raw materials: radix rehmanniae, rhizoma atractylodis, crab grass, serissa japonica, jasmine, red-spotted stonecrop, wolfberry, astragalus smicus, python gall, cocklebur, chamomile, concha haliotidis, Taiwan beautyberry, globe amaranth, pearl and weathered sodium sulfate powder. The eye drop is a pure traditional Chinese medicine preparation; is prepared by modern advanced pharmaceutical technologies; has efficacies of clearing away heat and purging pathogenic fire, relieving spasm and removing eyewinker, and nourishing the liver and improving visual acuity; and can be used for treating diminution of vision and pseudomyopia of teenagers, and reliving visual fatigue of eyes, and symptoms caused by visual fatigue such as conjunctival injection and eye itch. Compatibility of the selected raw materials is appropriate, curative effects are significant, safety performance is excellent, no side effects exist, cost is low, and the eye drop is worth of wide popularization and application.

The invention discloses a dendrobium officinale oculentum for relieving asthenopia, and relates to the field of eye health products. The dendrobium officinale oculentum for relieving asthenopia comprises the following raw materials in parts by weight: 30 to 50 parts of dendrobium officinale, 25 to 40 parts of fructus Lycii, 20 to 40 parts of semen cassiae, 20 to 40 parts of baical skullcap root, 20 to 40 parts of semen celosiae, 15 to 30 parts of semen plantaginis, 15 to 30 parts of peppermint, 15 to 30 parts of prunella vulgaris, 1500 to 3000 parts of oculentum substrate and a proper amount of water. The oculentum adopts a reasonable Chinese herbal medicine combination manner, realizes the pharmacological functions of eye pathological change prevention, vision diminution resistance and eye dryness relieving, and achieves the purpose of relieving asthenopia.

The invention disclosed is a method for decreasing the internal resistance or impedance of a battery or electrochemical cell is described which comprises the step of discharging the battery or cell until it reaches an overdischarge condition and maintaining the battery or cell in the overdischarge condition for a period of time sufficient to effect a diminution of the internal resistance or impedance of a battery or electrochemical cell; and a battery or electrochemical cell having a reduced impedance.

The invention discloses a display control method. The invention discloses a terminal and a computer readable storage medium. The objective of the invention is to solve a problem that when a terminal display screen outputs display information to a user, eye fatigues and diminution of vision of the user can be easily caused. The embodiment of the invention provides a display control scheme. When itis determined that an eye protection display mode needs to be entered; detecting an object viewing distance between a viewing object and a terminal display screen; determining a scaling ratio under the current visual object distance according to a mapping relation between the visual object distance and the scaling ratio of the display object; the display size of the display object on the display background is adjusted according to the determined scaling ratio; Therefore, the display size of the display object is matched with the object viewing distance between the viewing object and the display screen, the problem that the ideal object viewing distance cannot be correctly kept due to the poor object viewing habit of the viewing object and consequently the burden of eyes is intensified is avoided, the eyesight of a user is effectively protected under the condition that the user views the screen for a long time, and the user experience is improved.

A neuroprotective composition for protecting neuronal cells against oxidative stress and methods for using and preparing the same. More particularly, the neuroprotective composition of the invention comprises a mixture of pyruvate, antioxidant, and lipid(s) such as fatty acids. The neuroprotective composition could be used for the treatment of brain trauma, brain or cerebrovascular ischemia, neurodegenerative diseases, poisoning of neuronal cells, the diminution of drugs side effects and for preservation of neuronal grafts.

An object of the present invention is to provide a pharmaceutical agent or composition useful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, and a dermatological agent or composition suitable for skin applications, which can treat or prevent muscle weakening and inflammation, in particular arthritis, by its muscle-strengthening and/or anti-inflammatory actions, said agent or composition comprising isoflavone and/or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and/or scymnol and/or a scymnol ester. The present invention relates to an agent or composition usuful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, and/or an agent or composition to be applied to the skin, said agent or composition comprising isoflavone and/or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and/or scymnol and/or a scymnol ester.

The invention discloses a Chinese medicine preparation, comprising following raw materials by weight: 6.7-15.0 portions of tuber fleeceflower root, 8.4-19.0 portions of Chinese yam rhizome, 6.7-15.0 portions of hedge prinsepia nut flesh, 5.1-11.6 portions of black bean coat, 6.7-15.0 portions of burrerfly bush flower, 3.9-8.8 portions of anemarrhena, 6.7-15.0 portions of dwarf lilyturf tuber, 6.7-15.0 portions of tribulus terrestris, 2.6-5.8 portions of magnolia vine fruit and 13.3-30.0 portions of radix tangshen. The invention also discloses the application of the Chinese medicine preparation for treating the senile cataract and the diminution of vision, and a preparing method for preparing the Chinese medicine preparation. The invention provides the treatment principle of invigorating the liver and the kidney and benefiting vital energy based on the theory of traditional Chinese medicine to the senile cataract. The medicine can be prepared into conventional oral preparation, such as tablets, granules, capsules, oral liquid, and pills by the conventional method of the Chinese medicine preparation.

The invention provides a lumbar vertebra support device. The lumbar vertebra support device comprises a waist support belt, axilla stabilizing belt assemblies and two sets of same expansion and contraction devices, wherein each set of expansion and contraction device comprises a piston rod, a cylinder barrel, a piston and expansion and contraction springs positioned in the cylinder barrel, the top of each piston rod extends out of each corresponding cylinder barrel and is provided with an axilla support, the bottom of the piston rod is fixed to the upper end surface of the piston, and the top ends of the expansion and contraction springs push against the lower end surface of the piston; the cylinder barrels of the two sets of expansion and contraction devices are respectively connected to the waist support belt, and the axilla supports are connected with the axilla stabilizing belt assemblies. The lumbar vertebra support device can be used for correcting the sitting position of the human body, so that the diminution of vision caused by the too close distance between the eyes and the observed object is avoided, meanwhile, the extrusion from the gravity of the human upper body to the lumbar vertebra is alleviated, so that the stress applied to the lumbar vertebra of the lumbar vertebra patient is alleviated, and the lumbar vertebra support device has the adjuvant therapy and health effects for the lumbar vertebra patient.

A clear aqueous formulation for topical application in the oral cavity of humans to treat leukoplakia contains water, beta-carotene, a water miscible polyol, an unsaturated fatty acid ester, and a surfactant, preferably polyethoxylated castor oil or POE(20) sorbitan monooleate The formulation preferably also contains a pharmaceutically acceptable anti-oxidant, preferably d-alpha-tocopherol (vitamin E), and is in the form of an oral rinse or as a gel well suited for spreading on gums or other parts of the oral cavity. The formulation is applied in a gel form on a substantially regular daily basis to areas in the oral cavity where leukoplakia lesions are present. Persistent application of the gel results in substantial diminution or total elimination of the leukoplakia lesions.

The invention discloses a myopia-prevention desk lamp. An ultrasonic distance measuring instrument is arranged on the lateral side of a base of the desk lamp. When ultrasonic waves are horizontally emitted to a student body, the horizontal distance xcm from a book to the student body is obtained, the distance ycm from the desk top serving as a starting point to eyes of a student is inputted via a panel of the desk lamp, by calculating the result of x<2> + y<2> via a calculator in the base of the desk lamp, a trigger signal is transmitted to control on and off of the desk lamp through a control circuit. When the x<2> + y<2>>/=302cm<2>, the desk lamp is turned on, and when the x<2> + y<2></=302cm<2>, the desk lamp is turned off. On and off of a bulb of the desk lamp is controlled according to the measured distance, and accordingly, the student can be prompted of correct writing posture and distance, and the problem about sight diminution due to the fact that the student is too closer to books when writing or reading is solved.